SEC Filing Details

Document Details

Form

3

Filing Date

Sep 11, 2013

Document Date

Sep 9, 2013

Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group

3,4,5

Company

Regeneron Pharmaceuticals Inc.

Issuer

REGENERON PHARMACEUTICALS, INC.

Filer

Landry Robert E

Filing Formats

View HTML